# SynOmics: integrating multi-omics data through feature interaction networks

**Authors:** Muhtasim Noor Alif, Wei Zhang

PMC · DOI: 10.1093/bib/bbaf595 · Briefings in Bioinformatics · 2025-11-13

## TL;DR

SynOmics is a new framework that improves multi-omics data integration using graph networks, leading to better biomedical predictions.

## Contribution

Introduces SynOmics, a graph convolutional network framework that models both within- and cross-omics feature interactions for improved integration.

## Key findings

- SynOmics outperforms existing methods in multi-omics integration across biomedical classification tasks.
- The framework captures both intra-omics and inter-omics dependencies through parallel learning.
- It shows potential for biomarker discovery and clinical applications.

## Abstract

The integration of multi-omics data is essential for achieving a comprehensive understanding of molecular systems and enhancing the performance of predictive models in biomedical research. However, many existing models have limited capacity to capture cross-omics feature interactions, which hinders the depth of integration. In this study, we introduce SynOmics, a graph convolutional network framework designed to improve multi-omics integration by constructing omics networks in the feature space and modeling both within- and cross-omics dependencies. By incorporating both omics-specific networks and cross-omics bipartite networks, SynOmics enables simultaneous learning of intra-omics and inter-omics relationships. Unlike traditional approaches that rely on early or late integration strategies, SynOmics adopts a parallel learning strategy to process feature-level interactions at each layer of the model. Experimental results demonstrate that SynOmics consistently outperforms state-of-the-art multi-omics integration methods across a range of biomedical classification tasks, highlighting its potential for biomarker discovery and clinical applications.

## Full-text entities

- **Genes:** SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, EGLN3 (egl-9 family hypoxia inducible factor 3) [NCBI Gene 112399] {aka HIFP4H3, HIFPH3, PHD3}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, ADAM12 (ADAM metallopeptidase domain 12) [NCBI Gene 8038] {aka ADAM12-OT1, CAR10, MCMP, MCMPMltna, MLTN, MLTNA}, CLEC3B (C-type lectin domain family 3 member B) [NCBI Gene 7123] {aka MCDR4, TN, TNA}, IGFBP1 (insulin like growth factor binding protein 1) [NCBI Gene 3484] {aka AFBP, IBP1, IGF-BP25, PP12, hIGFBP-1}, COL11A1 (collagen type XI alpha 1 chain) [NCBI Gene 1301] {aka CO11A1, COLL6, DFNA37, STL2}, MFAP5 (microfibril associated protein 5) [NCBI Gene 8076] {aka AAT9, MAGP-2, MAGP2, MFAP-5, MP25}
- **Diseases:** Cancer (MESH:D009369), SD (MESH:D012735), LUAD cancer (MESH:D008175), inflammatory (MESH:D007249), breast cancer (MESH:D001943), LUAD (MESH:D000077192), ovarian serous cystadenocarcinoma (MESH:D010049)
- **Chemicals:** GCN (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12613832/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12613832/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12613832/full.md

---
Source: https://tomesphere.com/paper/PMC12613832